Wu J, Perrin D M, Sigman D S, Kaback H R
Howard Hughes Medical Institute, Department of Physiology, University of California, Los Angeles 90095-1662, USA.
Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9186-90. doi: 10.1073/pnas.92.20.9186.
Biotinylated lactose permease from Escherichia coli containing a single-cysteine residue at position 330 (helix X) or at position 147, 148, or 149 (helix V) was purified by avidin-affinity chromatography and derivatized with 5-(alpha-bromoacetamido)-1,10-phenanthroline-copper [OP(Cu)]. Studies with purified, OP(Cu)-labeled Leu-330 --> Cys permease in dodecyl-beta-D-maltopyranoside demonstrate that after incubation in the presence of ascorbate, cleavage products of approximately 19 and 6-8 kDa are observed on immunoblots with anti-C-terminal antibody. Remarkably, the same cleavage products are observed with permease embedded in the native membrane. Comparison with the C-terminal half of the permease expressed independently as a standard indicates that the 19-kDa product results from cleavage near the cytoplasmic end of helix VII, whereas the 6- to 8-kDa fragment probably results from fragmentation near the cytoplasmic end of helix XI. Results are entirely consistent with a tertiary-structure model of the C-terminal half of the permease derived from earlier site-directed fluorescence and site-directed mutagenesis studies. Similar studies with OP(Cu)-labeled Cys-148 permease exhibit cleavage products at approximately 19 kDa and at 15-16 kDa. The larger fragment probably reflects cleavage at a site near the cytoplasmic end of helix VII, whereas the 15- to 16-kDa fragment is consistent with cleavage near the cytoplasmic end of helix VIII. When OP(Cu) is moved 100 degrees to position 149 (Val-149 --> Cys permease), a single product is observed at 19 kDa, suggesting fragmentation at the cytoplasmic end of helix VII. However, when the reagent is moved 100 degrees in the other direction to position 147 (Gly-147 --> Cys permease), cleavage is not observed. The results suggest that helix V is in close proximity to helices VII and VIII with position 148 in the interface between the helices, position 149 facing helix VII, and position 147 facing the lipid bilayer.
来自大肠杆菌的生物素化乳糖通透酶在330位(螺旋X)或147、148或149位(螺旋V)含有单个半胱氨酸残基,通过抗生物素蛋白亲和层析进行纯化,并用5 -(α-溴乙酰胺基)-1,10 -菲咯啉 - 铜[OP(Cu)]进行衍生化。在十二烷基 - β - D - 麦芽吡喃糖苷中对纯化的、经OP(Cu)标记的Leu - 330→Cys通透酶进行的研究表明,在抗坏血酸存在下孵育后,用抗C末端抗体进行免疫印迹时观察到约19 kDa和6 - 8 kDa的裂解产物。值得注意的是,在嵌入天然膜的通透酶中也观察到相同的裂解产物。与独立表达作为标准的通透酶C末端一半进行比较表明,19 kDa产物是由螺旋VII细胞质末端附近的裂解产生的,而6至8 kDa片段可能是由螺旋XI细胞质末端附近的断裂产生的。结果与早期定点荧光和定点诱变研究得出的通透酶C末端一半的三级结构模型完全一致。对经OP(Cu)标记的Cys - 148通透酶进行的类似研究显示,裂解产物在约19 kDa和15 - 至16 kDa处。较大的片段可能反映了螺旋VII细胞质末端附近的裂解,而15至16 kDa片段与螺旋VIII细胞质末端附近的裂解一致。当OP(Cu)移动100°到149位(Val - 149→Cys通透酶)时,在19 kDa处观察到单一产物,表明在螺旋VII细胞质末端发生断裂。然而,当试剂向另一个方向移动100°到147位(Gly - 147→Cys通透酶)时,未观察到裂解。结果表明,螺旋V与螺旋VII和VIII紧密相邻,148位位于螺旋之间的界面,149位面向螺旋VII,147位面向脂质双层。